Christopher Hite - 05 Mar 2026 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Reporting relationship: Director
Issuer ticker: VERA
Reported as of: 05 Mar 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 09 Mar 2026, 16:49:21 UTC
Prior SEC filing: 13 Feb 2026
Next SEC filing: 16 Apr 2026
Source filing: View source filing
Reporting owner signature: /s/ Joseph R. Young, Attorney-in-Fact

Key filing fact

Christopher Hite filed Form 4 for Vera Therapeutics, Inc. (VERA) on 09 Mar 2026.

Key facts

This page summarizes Christopher Hite's Form 4 filing for Vera Therapeutics, Inc. (VERA).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 09 Mar 2026, 16:49.

Change

Previous filing in this sequence was filed on 13 Feb 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001814238 Primary reporting owner

Hite Christopher

Relationship: Director
Address: C/O VERA THERAPEUTICS, INC., 2000 SIERRA POINT PARKWAY, SUITE 1200, BRISBANE
Signature: /s/ Joseph R. Young, Attorney-in-Fact
Signature date: 09 Mar 2026

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

VERA transaction Derivative

Stock Option (right to buy)

Award

Transaction value
Shares: +24,937
Change %
Price: $0.000000^*
Shares after: 24,937
Date: 05 Mar 2026
Ownership: Direct
Underlying class: Class A Common Stock
Underlying amount: 24,937
Exercise price: $38.85
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares subject to the option will vest monthly over a three-year period, subject to the Reporting Person's continuous service on each vesting date.